Picture of Glaukos logo

GKOS — Glaukos News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Glaukos Corp expected to post a loss of 55 cents a share - Earnings Preview

* Glaukos Corp  GKOS.N   GKOS.K  is expected to show a rise
in
quarterly revenue when it reports  results on February 21 for
the period ending December 31 2023
    * The San Clemente California-based  company is expected to
report
a 10.5% increase in revenue to $78.688 million from $71.23
million a year ago, according to the mean estimate from 13
analysts, based on LSEG data.The company's guidance on January 9
2024, for the period ended December 31, was for revenue of
$81.000 million.
    * ​LSEG's mean analyst estimate for Glaukos Corp is for a
loss
of 55 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Glaukos
Corp is
$101.00​, above​ its last closing price of $92.63. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.54       -0.55      -0.50     Beat    8.9
 Jun. 30 2023  -0.56       -0.55      -0.55     Met     0.8
 Mar. 31 2023  -0.56       -0.58      -0.59     Missed  -2.6​
 Dec. 31 2022  -0.54       -0.55      -0.53     Beat    2.8
 ​​Sep.        -0.51       -0.52      -0.45     Beat    13.8
 30 2022                                                
 Jun. 30 2022  -0.43       -0.44      -0.83     Missed  -89.6​
 Mar. 31 2022  -0.49       -0.51      -0.38     Beat    24.8
 Dec. 31 2021  -0.36       -0.37      -0.31     Beat    16.7
 This summary was machine generated February 20 at 03:01 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Glaukos

See all news